Beyond talc pleurodesis: Do we really need new methods?

Respirology

Volumn 16, Issue 7, 2011, Pages 1020-1022

  Kalomenidis, Ioannis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

iodopovidone; malignant pleural effusion; pleurodesis; pneumothorax; silver nitrate

Indexed keywords

BLEOMYCIN; DOXYCYCLINE; POVIDONE IODINE; SILVER NITRATE; TALC; TRANSFORMING GROWTH FACTOR BETA; ZOLEDRONIC ACID;

ANTIINFLAMMATORY ACTIVITY; COMPARATIVE EFFECTIVENESS; DISEASE MODEL; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; EDITORIAL; HUMAN; INDWELLING CATHETER; MALIGNANT PLEURA EFFUSION; MALIGNANT PLEURAL EFFUSION; NONHUMAN; PATIENT SAFETY; PLEURA EFFUSION; PLEURISY; PLEURODESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPONTANEOUS PNEUMOTHORAX; TALC PLEURODESIS;

ANIMALS; PLEURAL EFFUSION; PLEURODESIS; SCLEROSING SOLUTIONS; SILVER NITRATE;

EID: 80053333165     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02023.x     Document Type: Editorial

References (28)

1. Roberts ME, Neville E, Berrisford RG, et al,. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: s32-40.
2. Janssen JP, Collier G, Astoul P, et al,. Safety of pleurodesis with talc poudrage in malignant pleural effusion: A prospective cohort study. Lancet 2007; 369: 1535-9. (Pubitemid 46670303)
3. Bridevaux PO, Tschopp JM, Cardillo G, et al,. Short term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax. Eur. Respir. J. 2011; Epub ahead of print, doi: 10.1183/09031936.00189710.
4. Maskell NA, Lee YC, Gleeson FV, et al,. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am. J. Respir. Crit. Care Med. 2004; 170: 377-82. (Pubitemid 39214610)
5. Dikensoy O, Light RW,. Alternative widely available, inexpensive agents for pleurodesis. Curr. Opin. Pulm. Med. 2005; 11: 340-4. (Pubitemid 41073160)
6. Agarwal R, Paul AS, Aggarwal AN, et al,. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology 2011; 16: 1064-9.
7. Tremblay A, Stather D, Kelly M,. Effect of repeated administration of low-dose silver nitrate for pleurodesis in a rabbit model. Respirology 2011; 16: 1070-5.
8. Guo Y, Tang K, Bilaceroglu S, et al,. Iodopovidone is as effective as doxycycline in producing pleurodesis in rabbits. Respirology 2010; 15: 119-25.
9. Agarwal R, Aggarwal AN, Gupta D, et al,. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir. Med. 2006; 100: 2043-7. (Pubitemid 44490275)
10. Neto JD, de Oliveira SF, Vianna SP, et al,. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions. Respirology 2010; 15: 115-18.
11. Caglayan B, Torun E, Turan D, et al,. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann. Surg. Oncol. 2008; 15: 2594-9.
12. Olivares-Torres CA, Laniado-Laborín R, Chávez-García C, et al,. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002; 122: 581-3. (Pubitemid 35002139)
13. Wagenfeld L, Zeitz O, Richard G,. Visual loss after povidone-iodine pleurodesis. N. Engl. J. Med. 2007; 357: 1264-5.
14. Mohsen TA, Zeid AA, Meshref M, et al,. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur. J. Cardiothorac. Surg. 2011; 40: 282-6.
15. Paschoalini Mda S, Vargas FS, Marchi E, et al,. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005; 128: 684-9. (Pubitemid 41140496)
16. Vargas FS, Antonangelo L, Capelozzi V, et al,. Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up. Chest 2002; 122: 2122-6. (Pubitemid 36051152)
17. Marchi E, Vargas FS, Acencio MM, et al,. Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits. Chest 2004; 125: 2268-77. (Pubitemid 38788199)
18. Marchi E, Vargas FS, Teixeira LR, et al,. Intrapleural low-dose silver nitrate elicits more pleural inflammation and less systemic inflammation than low-dose talc. Chest 2005; 128: 1798-804. (Pubitemid 41324478)
19. Marchi E, Vargas FS, Acencio MM, et al,. Low doses of silver nitrate induce pleurodesis with a limited systemic response. Respirology 2009; 14: 885-9.
20. Lee YC, Lane KB, Parker RE, et al,. Transforming growth factor beta(2) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000; 55: 1058-62.
21. Lee YCG, Teixeira LR, Devin CJ, et al,. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am. J. Respir. Crit. Care Med. 2001; 163: 640-4. (Pubitemid 32230822)
22. Kalomenidis I, Guo Y, Lane KB, et al,. Transforming growth factor-beta3 induces pleurodesis in rabbits and collagen production of human mesothelial cells. Chest 2005; 127: 1335-40. (Pubitemid 46224297)
23. Elliott RL, Blobe GC,. Role of transforming growth factor beta in human cancer. J. Clin. Oncol. 2005; 23: 2078-93. (Pubitemid 46211385)
24. Burgers JA, Kunst PW, Koolen MG, et al,. Pleural drainage and pleurodesis: implementation of guidelines in four hospitals. Eur. Respir. J. 2008; 32: 1321-7.
25. Stathopoulos GT, Psallidas I, Moustaki A, et al,. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J. Natl. Cancer Inst. 2008; 100: 1464-76.
26. Stathopoulos GT, Moschos C, Loutrari H, et al,. Zoledronic acid is effective against experimental malignant pleural effusion. Am. J. Respir. Crit. Care Med. 2008; 178: 50-9. (Pubitemid 351919193)
27. Kerbel RS,. Tumor angiogenesis. N. Engl. J. Med. 2008; 358: 2039-49. (Pubitemid 351656458)
28. Gratton JP, Lin MI, Yu J, et al,. Selective inhibition of tumor microvascularpermeability by cavtratin blocks tumor progression in mice. Cancer Cell 2003; 4: 31-9. (Pubitemid 36904159)